To include your compound in the COVID-19 Resource Center, submit it here.

Vector's new force on M&A front

Vaughn Bryson, former president and CEO of Eli Lilly and Co., has joined Vector Securities International Inc. as vice chairman of the board, adding a pharmaceutical industry perspective to the health care-focused investment banking firm.

In an interview with BioCentury, Bryson discussed his role at Vector and his perspective on alliances between

Read the full 517 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers